Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive carisbamate in partial onset seizures
2008-005098-37Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in epilepsy comparing Carisbamate adjunctive therapy with Placebo adjunctive therapy (2 arms). Primary endpoint: Responder rate. Started Sep 2008; status: completed.
02
Drugs
carisbamate
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2008-005098-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005098-37.